Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

Studying the effects of Narrowband Ultraviolet B versus acitretin on psoriatic patients

Compare the effects of Narrowband Ultraviolet B versus acitretin on serum Omentin-1 level in psoriatic patients as case control study by dividing patients into 3 groups: group 1 include patients receive Narrowband Ultraviolet B, group II includes patients receive acitretin (0.5-1 mg/day) and control group. The duration of this study about 3 months after receving those interventions.

Inclusion Criteria:

• Patients of both sexes with psoriasis vulgaris.

Exclusion Criteria:

• • Patients with history of malignancies, renal and liver diseases.

  • Patients received NB-UVB phototherapy in the last 6 months.
  • Patients treated with methotrexate or biologic agents and any systemic treatment of psoriasis.